Trial Outcomes & Findings for Genomic Sequencing for Childhood Risk and Newborn Illness (NCT NCT02422511)
NCT ID: NCT02422511
Last Updated: 2024-04-03
Results Overview
Days spent in inpatient care from disclosure of randomization status / genomic sequencing results through 10 months post-disclosure. Services were identified through a combination of chart note review, medical record review and participant surveys.
COMPLETED
NA
1205 participants
From disclosure through 10 Months post-disclosure (approx. 15 months after baseline).
2024-04-03
Participant Flow
Participant milestones
| Measure |
Well Baby Parents: Family History Only
Parents of newborns in well-baby units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only. Parents and their newborns are enrolled.
Family history report: Participants from all arms of the study have a family history taken by a study genetic counselor. Information collected through the family history is summarized in a family history report tand reviewed with all participants.
|
Well Babies: Family History Only
Newborns in well-baby units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only. Parents and their newborns are enrolled.
Family history report: Participants from all arms of the study have a family history taken by a study genetic counselor. Information collected through the family history is summarized in a family history report tand reviewed with all participants.
|
Well Baby Parents: Family History + Exome Sequencing
Parents of newborns in well-baby units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report. Parents and their newborns are enrolled.
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing receive a 'Genomic Newborn Sequencing Report' (GNSR) which includes pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study have a family history taken by a study genetic counselor. Information collected through the family history is summarized in a family history report that is reviewed with all participants.
|
Well Babies: Family History + Exome Sequencing
Newborns in well-baby units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report. Parents and their newborns are enrolled.
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing receive a 'Genomic Newborn Sequencing Report' (GNSR) which includes pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study have a family history taken by a study genetic counselor. Information collected through the family history is summarized in a family history report that is reviewed with all participants.
|
ICU Baby Parents: Family History Only
Parents of newborns in intensive care units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only. Parents and their newborns are enrolled.
Family history report: Participants from all arms of the study have a family history taken by a study genetic counselor. Information collected through the family history is summarized in a family history report that is reviewed with all participants.
|
ICU Babies: Family History Only
Newborns in intensive care units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only. Parents and their newborns are enrolled.
Family history report: Participants from all arms of the study have a family history taken by a study genetic counselor. Information collected through the family history is summarized in a family history report that is reviewed with all participants.
|
ICU Baby Parents: Family History + Exome Sequencing
Parents of newborns in intensive care units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report. Parents and their newborns are enrolled.
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing receive a 'Genomic Newborn Sequencing Report' (GNSR) which includes pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study have a family history taken by a study genetic counselor. Information collected through the family history is summarized in a family history report that is reviewed with all participants.
|
ICU Babies: Family History + Exome Sequencing
Newborns in intensive care units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report. Parents and their newborns are enrolled.
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing receive a 'Genomic Newborn Sequencing Report' (GNSR) which includes pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study have a family history taken by a study genetic counselor. Information collected through the family history is summarized in a family history report that is reviewed with all participants.
|
|---|---|---|---|---|---|---|---|---|
|
Overall Study
STARTED
|
255
|
128
|
257
|
129
|
66
|
33
|
68
|
34
|
|
Overall Study
Received Disclosure
|
158
|
79
|
194
|
97
|
43
|
21
|
38
|
19
|
|
Overall Study
COMPLETED
|
143
|
0
|
168
|
0
|
39
|
0
|
38
|
0
|
|
Overall Study
NOT COMPLETED
|
112
|
128
|
89
|
129
|
27
|
33
|
30
|
34
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Genomic Sequencing for Childhood Risk and Newborn Illness
Baseline characteristics by cohort
| Measure |
Well Baby Parents: Family History Only
n=255 Participants
Parents of newborns in well-baby units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
Well Babies: Family History Only
n=128 Participants
Newborns in well-baby units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
Well Baby Parents: Family History + Exome Sequencing
n=257 Participants
Parents of newborns in well-baby units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing will receive a 'Genomic Newborn Sequencing Report' (GNSR) which will include pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
Well Babies: Family History + Exome Sequencing
n=129 Participants
Newborns in well-baby units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing will receive a 'Genomic Newborn Sequencing Report' (GNSR) which will include pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
ICU Baby Parents: Family History Only
n=66 Participants
Parents of newborns in intensive care units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
ICU Babies: Family History Only
n=33 Participants
Newborns in intensive care units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
ICU Baby Parents: Family History + Exome Sequencing
n=68 Participants
Parents of newborns in intensive care units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing will receive a 'Genomic Newborn Sequencing Report' (GNSR) which will include pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
ICU Babies: Family History + Exome Sequencing
n=34 Participants
Newborns in intensive care units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing will receive a 'Genomic Newborn Sequencing Report' (GNSR) which will include pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
Total
n=970 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
128 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
129 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
33 Participants
n=8 Participants
|
0 Participants
n=8 Participants
|
34 Participants
n=24 Participants
|
324 Participants
n=42 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
255 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
257 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
66 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
68 Participants
n=8 Participants
|
0 Participants
n=24 Participants
|
646 Participants
n=42 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
0 Participants
n=8 Participants
|
0 Participants
n=24 Participants
|
0 Participants
n=42 Participants
|
|
Age, Continuous
|
34 years
STANDARD_DEVIATION 4.45 • n=5 Participants
|
.025 years
STANDARD_DEVIATION .016 • n=7 Participants
|
35 years
STANDARD_DEVIATION 4.60 • n=5 Participants
|
.027 years
STANDARD_DEVIATION .017 • n=4 Participants
|
32 years
STANDARD_DEVIATION 5.29 • n=21 Participants
|
.055 years
STANDARD_DEVIATION .039 • n=8 Participants
|
35 years
STANDARD_DEVIATION 5.38 • n=8 Participants
|
.060 years
STANDARD_DEVIATION .031 • n=24 Participants
|
34 years
STANDARD_DEVIATION 4.75 • n=42 Participants
|
|
Sex: Female, Male
Female
|
130 Participants
n=5 Participants
|
66 Participants
n=7 Participants
|
129 Participants
n=5 Participants
|
63 Participants
n=4 Participants
|
33 Participants
n=21 Participants
|
15 Participants
n=8 Participants
|
34 Participants
n=8 Participants
|
17 Participants
n=24 Participants
|
487 Participants
n=42 Participants
|
|
Sex: Female, Male
Male
|
125 Participants
n=5 Participants
|
62 Participants
n=7 Participants
|
128 Participants
n=5 Participants
|
66 Participants
n=4 Participants
|
33 Participants
n=21 Participants
|
18 Participants
n=8 Participants
|
34 Participants
n=8 Participants
|
17 Participants
n=24 Participants
|
483 Participants
n=42 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
20 Participants
n=5 Participants
|
15 Participants
n=7 Participants
|
9 Participants
n=5 Participants
|
9 Participants
n=4 Participants
|
7 Participants
n=21 Participants
|
5 Participants
n=8 Participants
|
1 Participants
n=8 Participants
|
1 Participants
n=24 Participants
|
67 Participants
n=42 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
196 Participants
n=5 Participants
|
88 Participants
n=7 Participants
|
212 Participants
n=5 Participants
|
107 Participants
n=4 Participants
|
55 Participants
n=21 Participants
|
25 Participants
n=8 Participants
|
64 Participants
n=8 Participants
|
30 Participants
n=24 Participants
|
777 Participants
n=42 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
39 Participants
n=5 Participants
|
25 Participants
n=7 Participants
|
36 Participants
n=5 Participants
|
13 Participants
n=4 Participants
|
4 Participants
n=21 Participants
|
3 Participants
n=8 Participants
|
3 Participants
n=8 Participants
|
3 Participants
n=24 Participants
|
126 Participants
n=42 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
1 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
0 Participants
n=8 Participants
|
0 Participants
n=24 Participants
|
2 Participants
n=42 Participants
|
|
Race (NIH/OMB)
Asian
|
28 Participants
n=5 Participants
|
10 Participants
n=7 Participants
|
31 Participants
n=5 Participants
|
8 Participants
n=4 Participants
|
2 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
4 Participants
n=8 Participants
|
1 Participants
n=24 Participants
|
84 Participants
n=42 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
0 Participants
n=8 Participants
|
2 Participants
n=8 Participants
|
1 Participants
n=24 Participants
|
3 Participants
n=42 Participants
|
|
Race (NIH/OMB)
Black or African American
|
12 Participants
n=5 Participants
|
9 Participants
n=7 Participants
|
8 Participants
n=5 Participants
|
2 Participants
n=4 Participants
|
3 Participants
n=21 Participants
|
2 Participants
n=8 Participants
|
1 Participants
n=8 Participants
|
0 Participants
n=24 Participants
|
37 Participants
n=42 Participants
|
|
Race (NIH/OMB)
White
|
194 Participants
n=5 Participants
|
89 Participants
n=7 Participants
|
185 Participants
n=5 Participants
|
79 Participants
n=4 Participants
|
57 Participants
n=21 Participants
|
27 Participants
n=8 Participants
|
57 Participants
n=8 Participants
|
27 Participants
n=24 Participants
|
715 Participants
n=42 Participants
|
|
Race (NIH/OMB)
More than one race
|
5 Participants
n=5 Participants
|
12 Participants
n=7 Participants
|
9 Participants
n=5 Participants
|
24 Participants
n=4 Participants
|
0 Participants
n=21 Participants
|
2 Participants
n=8 Participants
|
0 Participants
n=8 Participants
|
3 Participants
n=24 Participants
|
55 Participants
n=42 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
15 Participants
n=5 Participants
|
7 Participants
n=7 Participants
|
24 Participants
n=5 Participants
|
16 Participants
n=4 Participants
|
4 Participants
n=21 Participants
|
2 Participants
n=8 Participants
|
4 Participants
n=8 Participants
|
2 Participants
n=24 Participants
|
74 Participants
n=42 Participants
|
|
Region of Enrollment
United States
|
255 participants
n=5 Participants
|
128 participants
n=7 Participants
|
257 participants
n=5 Participants
|
129 participants
n=4 Participants
|
66 participants
n=21 Participants
|
33 participants
n=8 Participants
|
69 participants
n=8 Participants
|
34 participants
n=24 Participants
|
647 participants
n=42 Participants
|
PRIMARY outcome
Timeframe: From disclosure through 10 Months post-disclosure (approx. 15 months after baseline).Population: The analysis population included infants enrolled in the BabySeq project. Data was not available for all participants due to withdrawal or non-responsiveness to follow up surveys.
Days spent in inpatient care from disclosure of randomization status / genomic sequencing results through 10 months post-disclosure. Services were identified through a combination of chart note review, medical record review and participant surveys.
Outcome measures
| Measure |
Well Baby Family History Only
n=116 Participants
Newborns in well-baby units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
Well Baby Family History + Exome Sequencing
n=121 Participants
Newborns in well-baby units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing will receive a 'Genomic Newborn Sequencing Report' (GNSR) which will include pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
ICU Baby Family History Only
n=31 Participants
Newborns in intensive care units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
ICU Baby Family History + Exome Sequencing
n=30 Participants
Newborns in intensive care units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing will receive a 'Genomic Newborn Sequencing Report' (GNSR) which will include pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
|---|---|---|---|---|
|
Downstream Health Care Costs Attributable to BabySeq Project Disclosure: Days of Inpatient Care
|
0.1 Days
Standard Deviation 0.4
|
0.0 Days
Standard Deviation 0.3
|
3.1 Days
Standard Deviation 12.9
|
3.8 Days
Standard Deviation 12.9
|
PRIMARY outcome
Timeframe: From baseline through 10 post-disclosure, with time points varying by measure. (Post-disclosure approx. 5 months after baseline; 3-months approx. 8 months after baseline; 10-months approx. 15 months after baseline)Population: The analysis population included parents of infants enrolled in the BabySeq project. Data was not available for all participants due to withdrawal or non-responsiveness to follow up surveys.
Parents' Distress was assessed using validated scales measuring Anxiety and Depression, and a novel item assessing Blame with responses ranging from 1 to 5. Higher scores indicate more distress. Anxiety per the Edinburgh Postnatal Depression Scale anxiety subscale (baseline, post-disclosure, and 3 months; scores ranging from 0 to 9); Anxiety per the Generalized Anxiety Disorder Scale-7 (3 months and 10 months; scores ranging from 0 to 21); Depression per the Edinburgh Postnatal Depression Scale (baseline, post-disclosure, and 3 months; scores ranging from 0 to 30); Depression per the Patient Health Questionnaire-9 (3 months and 10 months; scores ranging from 0 to 30); Self-blame per a novel item (3 months and 10 months)
Outcome measures
| Measure |
Well Baby Family History Only
n=202 Participants
Newborns in well-baby units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
Well Baby Family History + Exome Sequencing
n=203 Participants
Newborns in well-baby units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing will receive a 'Genomic Newborn Sequencing Report' (GNSR) which will include pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
ICU Baby Family History Only
n=53 Participants
Newborns in intensive care units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
ICU Baby Family History + Exome Sequencing
n=60 Participants
Newborns in intensive care units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing will receive a 'Genomic Newborn Sequencing Report' (GNSR) which will include pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
|---|---|---|---|---|
|
Parents' Distress
Anxiety per the Generalized Anxiety Disorder Scale-7 - 3 months
|
2.4 score on a scale
Standard Deviation 2.99
|
2.47 score on a scale
Standard Deviation 2.83
|
3.34 score on a scale
Standard Deviation 3.77
|
3.72 score on a scale
Standard Deviation 4.52
|
|
Parents' Distress
Anxiety per the Edinburgh Postnatal Depression Scale anxiety subscale - baseline
|
2.6 score on a scale
Standard Deviation 1.83
|
2.75 score on a scale
Standard Deviation 1.83
|
3.04 score on a scale
Standard Deviation 2.1
|
3.28 score on a scale
Standard Deviation 2.05
|
|
Parents' Distress
Anxiety per the Edinburgh Postnatal Depression Scale anxiety subscale - Postdisclosure
|
2.19 score on a scale
Standard Deviation 1.86
|
2.34 score on a scale
Standard Deviation 1.91
|
2.44 score on a scale
Standard Deviation 2.29
|
2.56 score on a scale
Standard Deviation 1.83
|
|
Parents' Distress
Anxiety per the Edinburgh Postnatal Depression Scale anxiety subscale - 3 months
|
1.86 score on a scale
Standard Deviation 1.87
|
1.97 score on a scale
Standard Deviation 1.86
|
2.16 score on a scale
Standard Deviation 2.07
|
2.24 score on a scale
Standard Deviation 1.83
|
|
Parents' Distress
Anxiety per the Generalized Anxiety Disorder Scale-7 - 10 months
|
2.46 score on a scale
Standard Deviation 3.06
|
2.77 score on a scale
Standard Deviation 3.10
|
3.43 score on a scale
Standard Deviation 4.2
|
2.25 score on a scale
Standard Deviation 2.92
|
|
Parents' Distress
Depression per the Edinburgh Postnatal Depression Scale - baseline
|
4.68 score on a scale
Standard Deviation 3.62
|
4.96 score on a scale
Standard Deviation 3.64
|
6.51 score on a scale
Standard Deviation 4.69
|
6.69 score on a scale
Standard Deviation 4.72
|
|
Parents' Distress
Depression per the Edinburgh Postnatal Depression Scale - 3 months
|
3.53 score on a scale
Standard Deviation 3.45
|
3.96 score on a scale
Standard Deviation 3.68
|
5.13 score on a scale
Standard Deviation 4.90
|
4.54 score on a scale
Standard Deviation 4.33
|
|
Parents' Distress
Depression per the Patient Health Questionnaire-9 - 3 months
|
4.04 score on a scale
Standard Deviation 3.47
|
3.49 score on a scale
Standard Deviation 2.79
|
4.86 score on a scale
Standard Deviation 5.93
|
4.35 score on a scale
Standard Deviation 3.20
|
|
Parents' Distress
Depression per the Patient Health Questionnaire-9 - 10 months
|
3.79 score on a scale
Standard Deviation 3.04
|
3.96 score on a scale
Standard Deviation 3.21
|
5.20 score on a scale
Standard Deviation 6.25
|
4.42 score on a scale
Standard Deviation 3.05
|
|
Parents' Distress
novel item assessing Blame - 3 months
|
1.8 score on a scale
Standard Deviation 0.83
|
1.96 score on a scale
Standard Deviation 0.90
|
2.12 score on a scale
Standard Deviation 0.93
|
1.97 score on a scale
Standard Deviation 0.811
|
|
Parents' Distress
Depression per the Edinburgh Postnatal Depression Scale - postdisclosure
|
4.12 score on a scale
Standard Deviation 3.51
|
4.38 score on a scale
Standard Deviation 3.85
|
5.0 score on a scale
Standard Deviation 5.03
|
4.92 score on a scale
Standard Deviation 4.54
|
|
Parents' Distress
novel item assessing Blame - 10 months
|
1.95 score on a scale
Standard Deviation 0.89
|
1.78 score on a scale
Standard Deviation 0.86
|
2.39 score on a scale
Standard Deviation 1.10
|
1.87 score on a scale
Standard Deviation 0.70
|
PRIMARY outcome
Timeframe: From baseline through 10 post-disclosure, with time points varying by measure. (Post-disclosure approx. 5 months after baseline; 3-months approx. 8 months after baseline; 10-months approx. 15 months after baseline)Population: The analysis population included parents of infants enrolled in the BabySeq project. Data was not available for all participants due to withdrawal or non-responsiveness to follow up surveys.
Parent-Child Relationship was assessed using validated scales measuring parents' perceptions of parenting stress (General parenting stress per the Parenting Stress Index™, 4th Edition Short Form (10 months); scores range from 36 to 180), how vulnerable they perceive their child to be (Parents' perception of baby's vulnerability per the Vulnerable Baby Scale (baseline, postdisclosure, 3 months, 10 months); scores range from 4 to 20), and how they are bonding with their child (Parent-child bonding per the Mother-to-Infant Bonding Scale (baseline, postdisclosure, 3 months, 10 months); scores range from 0 to 24). Lower bonding scores indicate more problems with bonding. For other measures, higher scores indicate higher stress and perceptions of vulnerability.
Outcome measures
| Measure |
Well Baby Family History Only
n=212 Participants
Newborns in well-baby units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
Well Baby Family History + Exome Sequencing
n=212 Participants
Newborns in well-baby units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing will receive a 'Genomic Newborn Sequencing Report' (GNSR) which will include pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
ICU Baby Family History Only
n=54 Participants
Newborns in intensive care units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
ICU Baby Family History + Exome Sequencing
n=63 Participants
Newborns in intensive care units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing will receive a 'Genomic Newborn Sequencing Report' (GNSR) which will include pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
|---|---|---|---|---|
|
Parent-Child Relationship
Parent-child bonding per the Mother-to-Infant Bonding Scale - postdisclosure
|
1.18 score on a scale
Standard Deviation 1.64
|
1.15 score on a scale
Standard Deviation 1.45
|
1.05 score on a scale
Standard Deviation 1.25
|
0.95 score on a scale
Standard Deviation 1.21
|
|
Parent-Child Relationship
Parent-child bonding per the Mother-to-Infant Bonding Scale - 3 months
|
1.48 score on a scale
Standard Deviation 1.79
|
1.36 score on a scale
Standard Deviation 1.63
|
1.56 score on a scale
Standard Deviation 1.90
|
1.03 score on a scale
Standard Deviation 1.36
|
|
Parent-Child Relationship
Parent-child bonding per the Mother-to-Infant Bonding Scale - 10 months
|
1.47 score on a scale
Standard Deviation 1.81
|
1.45 score on a scale
Standard Deviation 1.81
|
1.74 score on a scale
Standard Deviation 3.14
|
1.30 score on a scale
Standard Deviation 1.57
|
|
Parent-Child Relationship
Vulnerable Baby Scale - baseline
|
9.02 score on a scale
Standard Deviation 2.82
|
9.11 score on a scale
Standard Deviation 2.82
|
13.01 score on a scale
Standard Deviation 3.88
|
13.54 score on a scale
Standard Deviation 3.58
|
|
Parent-Child Relationship
Vulnerable Baby Scale - postdisclosure
|
8.03 score on a scale
Standard Deviation 2.44
|
8.59 score on a scale
Standard Deviation 2.79
|
10.24 score on a scale
Standard Deviation 3.37
|
11.55 score on a scale
Standard Deviation 3.72
|
|
Parent-Child Relationship
Vulnerable Baby Scale - 3 months
|
8.17 score on a scale
Standard Deviation 2.63
|
8.27 score on a scale
Standard Deviation 2.79
|
9.77 score on a scale
Standard Deviation 3.61
|
9.84 score on a scale
Standard Deviation 3.32
|
|
Parent-Child Relationship
Vulnerable Baby Scale - 10 months
|
7.3 score on a scale
Standard Deviation 2.3
|
7.46 score on a scale
Standard Deviation 2.32
|
8.51 score on a scale
Standard Deviation 3.06
|
9.21 score on a scale
Standard Deviation 3.14
|
|
Parent-Child Relationship
Parent-child bonding per the Mother-to-Infant Bonding Scale - baseline
|
1.6 score on a scale
Standard Deviation 1.83
|
1.35 score on a scale
Standard Deviation 1.82
|
1.45 score on a scale
Standard Deviation 1.76
|
1.71 score on a scale
Standard Deviation 1.65
|
|
Parent-Child Relationship
Parenting Stress Index™, 4th Edition Short Form- 10 months
|
61.17 score on a scale
Standard Deviation 18.19
|
60.46 score on a scale
Standard Deviation 15.55
|
64.94 score on a scale
Standard Deviation 19.15
|
62.03 score on a scale
Standard Deviation 15.11
|
PRIMARY outcome
Timeframe: From baseline through 10 post-disclosure, with time points varying by measure. Post-disclosure approx. 5 months after baseline; 3-months approx. 8 months after baseline; 10-months approx. 15 months after baseline.Population: The analysis population included parents of infants enrolled in the BabySeq project. Data was not available for all participants due to withdrawal or non-responsiveness to follow up surveys.
Parents' Relationship was assessed using validated and novel measures of marital satisfaction using the Relationship satisfaction per the Kansas Marital Satisfaction Scale (3 months; scores ranging from 3 to 15), relationship conflict per a novel item (all time points; scores ranging from 1 to 5), and partner blame per a novel item (3 months and 10 months; scores ranging from 1 to 5). Higher scores on Satisfaction indicates more Satisfaction. Higher scores on Conflict and Blame indicate higher conflict and blame.
Outcome measures
| Measure |
Well Baby Family History Only
n=210 Participants
Newborns in well-baby units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
Well Baby Family History + Exome Sequencing
n=210 Participants
Newborns in well-baby units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing will receive a 'Genomic Newborn Sequencing Report' (GNSR) which will include pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
ICU Baby Family History Only
n=55 Participants
Newborns in intensive care units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
ICU Baby Family History + Exome Sequencing
n=62 Participants
Newborns in intensive care units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing will receive a 'Genomic Newborn Sequencing Report' (GNSR) which will include pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
|---|---|---|---|---|
|
Parents' Relationship
Kansas Marital Satisfaction Scale - 3 months
|
15.0 score on a scale
Standard Deviation 2.47
|
13.14 score on a scale
Standard Deviation 2.12
|
12.94 score on a scale
Standard Deviation 2.12
|
12.92 score on a scale
Standard Deviation 2.34
|
|
Parents' Relationship
relationship conflict - baseline
|
1.92 score on a scale
Standard Deviation 0.77
|
1.99 score on a scale
Standard Deviation 0.75
|
2.01 score on a scale
Standard Deviation 0.80
|
1.87 score on a scale
Standard Deviation 0.76
|
|
Parents' Relationship
relationship conflict - postdisclosure
|
2.01 score on a scale
Standard Deviation 0.74
|
2.09 score on a scale
Standard Deviation 0.75
|
1.89 score on a scale
Standard Deviation 0.77
|
2.02 score on a scale
Standard Deviation 0.76
|
|
Parents' Relationship
relationship conflict - 3 months
|
2.0 score on a scale
Standard Deviation 0.74
|
2.17 score on a scale
Standard Deviation 0.74
|
2.05 score on a scale
Standard Deviation 0.90
|
2.02 score on a scale
Standard Deviation 0.75
|
|
Parents' Relationship
relationship conflict - 10 months
|
2.09 score on a scale
Standard Deviation 0.83
|
2.21 score on a scale
Standard Deviation 0.78
|
2.27 score on a scale
Standard Deviation 1.12
|
2.04 score on a scale
Standard Deviation 0.82
|
|
Parents' Relationship
partner blame 3 months
|
1.69 score on a scale
Standard Deviation 0.64
|
1.86 score on a scale
Standard Deviation 0.81
|
2.03 score on a scale
Standard Deviation 0.85
|
1.85 score on a scale
Standard Deviation 0.71
|
|
Parents' Relationship
partner blame 10 months
|
1.87 score on a scale
Standard Deviation 0.79
|
1.72 score on a scale
Standard Deviation 0.71
|
2.13 score on a scale
Standard Deviation 0.91
|
1.71 score on a scale
Standard Deviation 0.46
|
PRIMARY outcome
Timeframe: From disclosure through 10 Months post-disclosure (approx. 15 months after baseline)Per-patient counts for number of health care provider visits. Services were identified through a combination of chart note review, medical record review and participant surveys.
Outcome measures
| Measure |
Well Baby Family History Only
n=116 Participants
Newborns in well-baby units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
Well Baby Family History + Exome Sequencing
n=121 Participants
Newborns in well-baby units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing will receive a 'Genomic Newborn Sequencing Report' (GNSR) which will include pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
ICU Baby Family History Only
n=31 Participants
Newborns in intensive care units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
ICU Baby Family History + Exome Sequencing
n=30 Participants
Newborns in intensive care units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing will receive a 'Genomic Newborn Sequencing Report' (GNSR) which will include pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
|---|---|---|---|---|
|
Downstream Health Care Utilization Attributable to BabySeq Project Disclosure: Number of Health Care Provider Visits
|
5.4 # of Visits
Standard Deviation 6.3
|
5.9 # of Visits
Standard Deviation 6.1
|
4.9 # of Visits
Standard Deviation 7.4
|
6.3 # of Visits
Standard Deviation 7.2
|
PRIMARY outcome
Timeframe: From disclosure through 10 Months post-disclosure (approx. 15 months after baseline)Per-patient counts for number of current medications at 10 months. Services were identified through a combination of chart note review, medical record review and participant surveys.
Outcome measures
| Measure |
Well Baby Family History Only
n=116 Participants
Newborns in well-baby units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
Well Baby Family History + Exome Sequencing
n=121 Participants
Newborns in well-baby units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing will receive a 'Genomic Newborn Sequencing Report' (GNSR) which will include pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
ICU Baby Family History Only
n=31 Participants
Newborns in intensive care units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
ICU Baby Family History + Exome Sequencing
n=30 Participants
Newborns in intensive care units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing will receive a 'Genomic Newborn Sequencing Report' (GNSR) which will include pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
|---|---|---|---|---|
|
Downstream Health Care Utilization Attributable to BabySeq Project Disclosure: Number of Current Medications at 10 Months
|
1.7 # of current medications at 10 mont
Standard Deviation 4.9
|
1.4 # of current medications at 10 mont
Standard Deviation 3.2
|
0.5 # of current medications at 10 mont
Standard Deviation 1.0
|
1.8 # of current medications at 10 mont
Standard Deviation 4.0
|
PRIMARY outcome
Timeframe: From disclosure through 10 Months post-disclosure (approx. 15 months after baseline)Per-patient counts number of ER visits. Services were identified through a combination of chart note review, medical record review and participant surveys.
Outcome measures
| Measure |
Well Baby Family History Only
n=116 Participants
Newborns in well-baby units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
Well Baby Family History + Exome Sequencing
n=121 Participants
Newborns in well-baby units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing will receive a 'Genomic Newborn Sequencing Report' (GNSR) which will include pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
ICU Baby Family History Only
n=31 Participants
Newborns in intensive care units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
ICU Baby Family History + Exome Sequencing
n=30 Participants
Newborns in intensive care units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing will receive a 'Genomic Newborn Sequencing Report' (GNSR) which will include pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
|---|---|---|---|---|
|
Downstream Health Care Utilization Attributable to BabySeq Project Disclosure: Number of ER Visits
|
0.3 # of ER visits
Standard Deviation 0.7
|
0.4 # of ER visits
Standard Deviation 0.8
|
0.5 # of ER visits
Standard Deviation 1.1
|
0.3 # of ER visits
Standard Deviation 0.7
|
PRIMARY outcome
Timeframe: From disclosure through 10 Months post-disclosure (approx. 15 months after baseline)Per-patient counts for number of outpatient lab tests after results disclosure. Services were identified through a combination of chart note review, medical record review and participant surveys.
Outcome measures
| Measure |
Well Baby Family History Only
n=116 Participants
Newborns in well-baby units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
Well Baby Family History + Exome Sequencing
n=121 Participants
Newborns in well-baby units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing will receive a 'Genomic Newborn Sequencing Report' (GNSR) which will include pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
ICU Baby Family History Only
n=31 Participants
Newborns in intensive care units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
ICU Baby Family History + Exome Sequencing
n=30 Participants
Newborns in intensive care units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing will receive a 'Genomic Newborn Sequencing Report' (GNSR) which will include pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
|---|---|---|---|---|
|
Downstream Health Care Utilization Attributable to BabySeq Project Disclosure: Number of Outpatient Lab Tests
|
0.2 # of Outpatient Lab Tests
Standard Deviation 1.1
|
0.1 # of Outpatient Lab Tests
Standard Deviation 0.6
|
0.0 # of Outpatient Lab Tests
Standard Deviation 0.2
|
0.1 # of Outpatient Lab Tests
Standard Deviation 0.4
|
PRIMARY outcome
Timeframe: From disclosure through 10 Months post-disclosure (approx. 15 months after baseline)Population: The analysis population included infants enrolled in the BabySeq project. Data was not available for all participants due to withdrawal or non-responsiveness to follow up surveys.
Per-patient means (SDs) for healthcare costs (in U.S. dollars) after disclosure of randomization status / genomic results from the BabySeq project. Services were identified through a combination of chart note review, medical record review and participant surveys.
Outcome measures
| Measure |
Well Baby Family History Only
n=116 Participants
Newborns in well-baby units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
Well Baby Family History + Exome Sequencing
n=121 Participants
Newborns in well-baby units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing will receive a 'Genomic Newborn Sequencing Report' (GNSR) which will include pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
ICU Baby Family History Only
n=31 Participants
Newborns in intensive care units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
ICU Baby Family History + Exome Sequencing
n=30 Participants
Newborns in intensive care units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing will receive a 'Genomic Newborn Sequencing Report' (GNSR) which will include pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
|---|---|---|---|---|
|
Downstream Health Care Utilization Attributable to BabySeq Project Disclosure
Cost of Days Inpatient / Inpatient Care
|
424 U.S. dollars
Standard Deviation 2230
|
301 U.S. dollars
Standard Deviation 2389
|
23472 U.S. dollars
Standard Deviation 114624
|
25012 U.S. dollars
Standard Deviation 87820
|
|
Downstream Health Care Utilization Attributable to BabySeq Project Disclosure
Cost of Labs / Total
|
1972 U.S. dollars
Standard Deviation 3305
|
1958 U.S. dollars
Standard Deviation 3019
|
25872 U.S. dollars
Standard Deviation 114756
|
26891 U.S. dollars
Standard Deviation 87456
|
|
Downstream Health Care Utilization Attributable to BabySeq Project Disclosure
Cost of Visits / Outpatient services
|
1348 U.S. dollars
Standard Deviation 1645
|
1440 U.S. dollars
Standard Deviation 1623
|
1144 U.S. dollars
Standard Deviation 1603
|
1762 U.S. dollars
Standard Deviation 2261
|
|
Downstream Health Care Utilization Attributable to BabySeq Project Disclosure
Cost of Med # / Medications (OOP)
|
24 U.S. dollars
Standard Deviation 85
|
17 U.S. dollars
Standard Deviation 57
|
1194 U.S. dollars
Standard Deviation 6587
|
45 U.S. dollars
Standard Deviation 95
|
|
Downstream Health Care Utilization Attributable to BabySeq Project Disclosure
Cost of ER Visits / Equipment (OOP)
|
176 U.S. dollars
Standard Deviation 312
|
200 U.S. dollars
Standard Deviation 400
|
62 U.S. dollars
Standard Deviation 105
|
72 U.S. dollars
Standard Deviation 158
|
SECONDARY outcome
Timeframe: From Baseline to 3 Months post-disclosure (approx. 8 months after baseline)Population: The analysis population included parents of infants enrolled in the BabySeq project. Data was not available for all participants due to withdrawal or non-responsiveness to follow up surveys.
A novel survey item asked participants to rate the usefulness of whole genome sequencing results for managing health on a 1-10 scale at baseline and 3 months post-disclosure. Responses were on a 10-point scale anchored by "not at all useful" (1) to "extremely useful" (10).
Outcome measures
| Measure |
Well Baby Family History Only
n=201 Participants
Newborns in well-baby units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
Well Baby Family History + Exome Sequencing
n=204 Participants
Newborns in well-baby units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing will receive a 'Genomic Newborn Sequencing Report' (GNSR) which will include pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
ICU Baby Family History Only
n=53 Participants
Newborns in intensive care units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
ICU Baby Family History + Exome Sequencing
n=60 Participants
Newborns in intensive care units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing will receive a 'Genomic Newborn Sequencing Report' (GNSR) which will include pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
|---|---|---|---|---|
|
Change in Perceived Utility Toward Genomic Sequencing
perceived utility - 3 months
|
3.83 score on a scale
Standard Deviation 0.91
|
4.23 score on a scale
Standard Deviation 0.83
|
4.10 score on a scale
Standard Deviation 0.79
|
4.25 score on a scale
Standard Deviation 0.77
|
|
Change in Perceived Utility Toward Genomic Sequencing
perceived utility - baseline
|
3.78 score on a scale
Standard Deviation 0.86
|
3.77 score on a scale
Standard Deviation 0.95
|
4.13 score on a scale
Standard Deviation 0.81
|
3.76 score on a scale
Standard Deviation 1.02
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Post-disclosure approx. 5 months after baselinePopulation: The analysis population included parents of infants enrolled in the BabySeq project. Data was not available for all participants due to withdrawal or non-responsiveness to follow up surveys.
A novel item assessed participants' subjective understanding of their study results on a 1-5 scale, where higher scores indicate greater subjective understanding.
Outcome measures
| Measure |
Well Baby Family History Only
n=143 Participants
Newborns in well-baby units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
Well Baby Family History + Exome Sequencing
n=163 Participants
Newborns in well-baby units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing will receive a 'Genomic Newborn Sequencing Report' (GNSR) which will include pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
ICU Baby Family History Only
n=35 Participants
Newborns in intensive care units receive an Annotated Family History Report only. Active Comparator: Standard of Care Only: Family History report only
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
ICU Baby Family History + Exome Sequencing
n=35 Participants
Newborns in intensive care units receive a Genome Report and an Annotated Family History Report. Main Study Experimental: Genome Report and Family History report
Genomic sequencing: Both sick and healthy infants randomized to receive genomic sequencing will receive a 'Genomic Newborn Sequencing Report' (GNSR) which will include pathogenic or likely pathogenic variants identified in genes associated with childhood-onset disease.
Family history report: Participants from all arms of the study will have a family history taken by a study genetic counselor. Information collected through the family history will be summarized in a family history report that will be reviewed with all participants.
|
|---|---|---|---|---|
|
Understanding
|
3.69 score on a scale
Standard Deviation 0.55
|
3.37 score on a scale
Standard Deviation 0.70
|
3.51 score on a scale
Standard Deviation 0.70
|
3.14 score on a scale
Standard Deviation 0.60
|
Adverse Events
Well Baby Parents: Family History Only
Well Babies: Family History Only
Well Baby Parents: Family History + Exome Sequencing
Well Babies: Family History + Exome Sequencing
ICU Baby Parents: Family History Only
ICU Babies: Family History Only
ICU Baby Parents: Family History + Exome Sequencing
ICU Babies: Family History + Exome Sequencing
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place